ATAI Investor Day Presentation Deck
January 2022, 42 slides
  1. ATAI
  2. Related Decks
  3. Investor Day Presentation Decks
cognitive impairment associated with schizophrenia a | ATAI
| ATAI
agenda | ATAI
enabling technologies to aim for i ail platform anda strong cash of | ATAI
| ATAI
| ATAI
the opportunity of cognitive impairment in schizophrenia major cause of disability with no approved treatment on | ATAI
disclosure | ATAI
schizophrenia is a leading cause of disability | ATAI
people with schizophrenia in the united states rarely marry or find jobs and may end up homeless at some point | ATAI
the economic burden of schizophrenia | ATAI
severity and profile of cognitive impairment in schizophrenia | ATAI
disability in schizophrenia is primarily caused by cognitive impairment | ATAI
the large majority of patients with schizophrenia have cognitive impairment | ATAI
why are there no approved treatments for | ATAI
positive developments clearly recognizes the severity of the unmet need and continues to be open to expediting drug development programs the potential economic gain to society for a successful treatment of is enormous and likely to be welcomed by private and government | ATAI
key phase and programs in progress | ATAI
change from in the overall composite score | ATAI
development phase a data | ATAI
| ATAI
a well tolerated that potently enhances synaptic plasticity elicits statistically significant clinically meaningful effects on learning memory | ATAI
| ATAI
| ATAI
positive in broad range clinical models multiple species | ATAI
| ATAI
pro cognitive effects translate to humans | ATAI
development in cognitive deficits have highest impact on everyday functioning area critical target for improving | ATAI
a a wae cognitive improvements seen at the doses in prior studies | ATAI
| ATAI
train | ATAI
| ATAI
| ATAI
evaluate independent cohorts dosed with or tid | ATAI
| ATAI
| ATAI
| ATAI
a | ATAI
| ATAI
| ATAI
poi | ATAI
| ATAI
| ATAI
See More
ATAI
Investor Day Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Drug development
Life science
Recent decks by ATAI
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
See all presentations by ATAI (13 decks)
Related decks
Comera
SPAC
January 2022
Teknova
IPO
June 2021
AbCellera
Investor Conference
May 2022
Sharecare
SPAC
February 2021
Comera
Investor Presentation
December 2023
AbCellera
Investor Conference
September 2021
AbCellera
Results
August 2021
AbCellera
Investor Conference
April 2023
Recent decks by ATAI
See all presentations (13 decks)
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Comera
SPAC
January 2022
Teknova
IPO
June 2021
AbCellera
Investor Conference
May 2022
Sharecare
SPAC
February 2021
Comera
Investor Presentation
December 2023
AbCellera
Investor Conference
September 2021
AbCellera
Results
August 2021
AbCellera
Investor Conference
April 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io